Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global ICSI Injection Micropipettes Market Research Report 2026
Global ICSI Injection Micropipettes Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-08-14
Pages: 146 Pages
Report ld: 5676173
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY FINDINGS
ICSI accounts for around 73% of fertilization treatments worldwide and remains the dominant assisted fertilization technique
Mainstream international channel prices are approximately US$18–20 per micropipette, commonly supplied in packs of ten
Spiked designs and inner diameters below 6 μm form the core configuration of mainstream clinical ICSI micropipettes
Fertility clinics and IVF centers constitute the primary downstream users, while hospital reproductive centers provide another major demand base
ICSI Injection Micropipettes Market Size(US$)
CAGR 2026-2032
5.4%
Market Size,2032
USD 55.96
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 40.79 million
Market Forecast in 2032(Value)
US$ 55.96 million
CAGR
5.4%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global ICSI Injection Micropipettes market was valued at US$ 38.72 million in 2025 and is anticipated to reach US$ 55.96 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
ICSI Injection Micropipette is a specialized micromanipulation tool used in assisted reproductive laboratories for intracytoplasmic sperm injection. It is typically manufactured from fine glass capillary tubing with a sharp, beveled or spiked tip and is operated together with a micromanipulator and microinjection system. Its primary function is to aspirate and control a selected and immobilized single sperm under microscopic observation, penetrate the zona pellucida and oolemma of a stabilized oocyte, and release the sperm directly into the ooplasm to complete intracytoplasmic sperm injection. Product design focuses on tip configuration, lumen geometry, taper profile, bending angle, surface finish and manufacturing consistency to provide reliable sperm handling, controlled oocyte penetration and precise cytoplasmic injection while minimizing mechanical damage to the oocyte. ICSI micropipettes are specialized consumables for assisted reproductive micromanipulation and are functionally distinct from holding pipettes, which are used to stabilize the oocyte during the injection procedure.
MARKET TRENDS
The ICSI Injection Micropipette market is evolving from basic glass injection tools toward highly standardized microtools optimized for reproducibility, lower oocyte trauma and embryologist-specific handling preferences. Major suppliers increasingly offer multiple combinations of spike design, lumen diameter, taper geometry, bend angle and tip-to-bend distance rather than a single universal specification. Long parallel-wall and slim designs are being developed to improve fluid control and reduce entry diameter, while rigid short-taper designs remain important for users seeking greater puncture stiffness. Large-bore models address surgically retrieved sperm, and flat-tip or dedicated Piezo injection pipettes are expanding the technical range of the market. Manufacturing is also becoming more controlled: CooperSurgical uses automated production and repeated dimensional inspection, while Kitazato and ASTEC emphasize individually inspected precision manufacturing and ICSION offers customized specifications. Cleanroom manufacture, individual sterile packaging, traceability, MEA and endotoxin testing are increasingly becoming core purchasing considerations rather than secondary features.
MARKET SEGMENTATION
By Company
- CooperSurgical
- Nexpring Health
- Vitrolife
- Kitazato
- Sunlight Medical
- VITROMED
- ASTEC
- Labotect
- Thomas Medical
- Microtech IVF
- Synga
- ARSCI
- Optimas
- ICSION Medical
- Monash Biotech
- Reproline medical
- TechBruein
- SASOmed
- VitaVitro
- DEWIN
- WEGO Shingene Medical
- Lingen Precision Medical Products
- Diagens Bio
- Minvitro
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Spiked
- Non-Spiked
Segment by Application
- Fertility Clinics and IVF Centers
- Hospital-Based Reproductive Medicine Centers
- Academic and Research Laboratories
- Others
Segment by Category
- <5.0 μm
- 5.0–<6.0 μm
- ≥6.0 μm
Segment by Division
- Long Parallel-Wall
- Short Parallel-Wall
- Rigid-Taper
MARKET DYNAMICS
Drivers
Demand is fundamentally supported by the large and recurring global ART treatment base and the high penetration of ICSI within assisted fertilization. ESHRE reports more than three million registered ART cycles annually worldwide and estimates actual activity at around four million cycles after allowing for incomplete registry coverage; ICSI accounts for about 73% of fertilization treatments. Male-factor infertility remains the core clinical foundation for ICSI, while previous poor or failed fertilization and selected use after oocyte cryopreservation provide additional procedure demand. Because ICSI requires direct sperm aspiration and oocyte injection through a precision microtool, each expansion in the number of ICSI-performing embryology laboratories generates recurring demand for sterile single-use injection micropipettes.
Restraints
The market is constrained by the already-high penetration of ICSI, slowing ART growth in some mature markets and the relatively low value of each disposable micropipette. ESHRE notes that ART cycle growth in many developed countries has historically been in the mid- to high-single-digit range but is showing signs of moderation, while CooperSurgical also reported periods of softer fertility activity during 2025. In addition, broader use of ICSI is not automatically supported for every non-male-factor IVF cycle; the 2026 ASRM committee opinion continues to distinguish clearly indicated ICSI from routine use in patients with normal semen parameters. These factors limit the extent to which growth can be generated simply by increasing ICSI penetration, making treatment volume, geographic expansion and supplier share gains more important.
Opportunities
The strongest opportunities lie in geographic expansion, localized manufacturing and increasingly differentiated microtool designs. Major suppliers are expanding distribution into North America, Europe and Asia, while Chinese manufacturers such as VitaVitro, DEWIN and Minvitro have established domestic ICSI injection or micromanipulation product lines, creating additional substitution opportunities in a market historically led by imported microtools. Product-level opportunities are emerging around lower-trauma slim designs, customized dimensions, large-bore pipettes for surgically retrieved sperm and Piezo-compatible injection pipettes. ICSION already supplies dedicated Piezo injection models and CooperSurgical offers flat-tip products for Piezo-ICSI, while DEWIN also includes Piezo tools within its micromanipulation portfolio. Customized production is particularly attractive because embryologists often maintain strong preferences for taper stiffness, fluid response, spike shape and bend geometry.
Challenges
ICSI micropipettes are structurally simple but demanding to manufacture consistently because minute variations in inner diameter, bevel, spike formation, taper length, bend angle or surface defects can materially change handling characteristics during microinjection. Suppliers must therefore combine precision glass processing with cleanroom control, dimensional inspection, sterilization and embryo-compatible biological testing. CooperSurgical performs full visual inspection throughout production and uses gamma sterilization together with MEA and LAL testing, while Labotect uses individually sterile packaging and validated electron-beam sterilization. Another challenge is that embryologist preference is highly operator-specific: flexible long-parallel tapers, rigid short tapers, spiked tips and non-spiked tips can all be preferred in different laboratories. This limits complete SKU standardization, increases high-mix manufacturing requirements and makes clinical familiarity, training, distributor support and reliable supply important competitive factors alongside price.
INDUSTRY CHAIN ANALYSIS
The upstream chain is centered on high-purity borosilicate glass capillary tubing, polymer holders and protective packaging, precision forming and inspection equipment, cleanroom infrastructure and sterilization services. Midstream production involves capillary cleaning, heating and pulling, taper formation, lumen control, beveling and spike fabrication, bending, polishing, dimensional inspection, cleaning, sterile packaging and biological quality control. CooperSurgical explicitly identifies cleaning, heating and sonication of borosilicate capillaries as part of its process, while VITROMED manufactures injection pipettes from specially cleaned borosilicate glass under cleanroom conditions. Finished products reach users through global direct-sales organizations and specialist IVF distributors, with independent fertility clinics, IVF centers and hospital reproductive medicine laboratories forming the principal clinical customer base and academic or research laboratories representing a smaller specialized segment. The value added is concentrated less in raw glass cost than in precision processing, process reproducibility, quality assurance, regulatory compliance and dependable global distribution.
SEGMENT INSIGHTS
By tip configuration, spiked ICSI micropipettes remain the mainstream architecture. CooperSurgical states that most of its ORIGIO ICSI micropipettes use fine spikes, while Vitrolife and Kitazato maintain extensive spiked product ranges; non-spiked products remain relevant for embryologists preferring a sharp bevel without an additional spike. By inner diameter, products below 5.0 μm and those from 5.0 to below 6.0 μm cover the core conventional ICSI range, reflecting the need to balance sperm aspiration, fluid control and a small oocyte entry point. Products at 6.0 μm and above form a more specialized segment, including designs intended to facilitate handling of surgically retrieved sperm or spermatids. By taper design, long parallel-wall products emphasize fine fluid control and flexibility, short parallel-wall products provide a different balance between control and stiffness, and rigid-taper designs serve embryologists who prefer greater tip rigidity during penetration. The continued coexistence of these designs indicates that operator preference and laboratory technique remain important determinants of product selection.
DOWNSTREAM MARKET OPPORTUNITIES
Independent fertility clinics and IVF centers account for the principal commercial demand because ICSI is performed routinely in dedicated embryology laboratories equipped with inverted microscopes, micromanipulators and injection systems. Hospital-based reproductive medicine centers constitute another important customer segment, particularly in markets where ART services are concentrated in university hospitals, maternity hospitals or large medical systems. Academic and research laboratories represent a much smaller but technically important market for micromanipulation research, embryology training and method development. Future downstream opportunities are increasingly associated with large IVF clinic groups seeking standardized consumables across multiple laboratories, expansion of ART capacity in emerging markets, increasing treatment of complex male-factor infertility and greater demand for product traceability and consistent handling performance. Specialized clinical scenarios such as surgically retrieved sperm and Piezo-ICSI also support higher product differentiation even though they remain smaller than conventional ICSI.
REGIONAL INSIGHTS
Europe and North America remain major high-value markets for ICSI Injection Micropipettes because of their mature ART infrastructure, extensive clinic networks and established use of regulated single-use laboratory consumables. Europe represents an exceptionally large documented ART base, while the United States combines substantial procedure volume with relatively high consumable pricing. Asia-Pacific provides the largest long-term volume opportunity through major ART markets including China and Japan, although near-term treatment growth can vary significantly by country. ESHRE identifies China at around one million ART cycles annually and Japan as one of the world's most active officially reported ART markets, while Kitazato identifies the United States, Europe, China and other overseas markets as strategic areas for continued expansion. Regional competition is also becoming more localized: European and North American brands retain strong premium positions, while Chinese suppliers are broadening domestic ICSI microtool portfolios and international registrations.
Fastest-Growing Region: Asia Pacific
Europe and North America remain major high-value markets for ICSI Injection Micropipettes because of their mature ART infrastructure, extensive clinic networks and established use of regulated single-use laboratory consumables. Europe represents an exceptionally large documented ART base, while the United States combines substantial procedure volume with relatively high consumable pricing. Asia-Pacific provides the largest long-term volume opportunity through major ART markets including China and Japan, although near-term treatment growth can vary significantly by country. ESHRE identifies China at around one million ART cycles annually and Japan as one of the world's most active officially reported ART markets, while Kitazato identifies the United States, Europe, China and other overseas markets as strategic areas for continued expansion. Regional competition is also becoming more localized: European and North American brands retain strong premium positions, while Chinese suppliers are broadening domestic ICSI microtool portfolios and international registrations.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
BY TYPE,2021-2032(US $ MILLION)
Spiked
Non-Spiked
BY APPLICATION，2021-2032(US $ MILLION）
Fertility Clinics and IVF Centers
Hospital-Based Reproductive Medicine Centers
Academic and Research Laboratories
Others
COMPETITIVE LANDSCAPE ANALYSIS
The competitive landscape combines diversified global ART platforms with highly specialized micropipette manufacturers and increasingly capable regional suppliers. CooperSurgical has one of the strongest manufacturing positions, producing more than 1.5 million ORIGIO micropipettes annually across ICSI and other micromanipulation applications, while Vitrolife and Kitazato combine ICSI microtools with broader IVF consumable portfolios. Nexpring Health has emerged as an important consolidated ART platform incorporating Cook Reproductive Health, Hamilton Thorne, Gynemed, Gynétics, IVFtech, Planer and Irvine Scientific. Sunlight Medical, VITROMED, ASTEC, Labotect, Microtech IVF, Synga, ICSION Medical, ARSCI and Optimas compete through specialist microtool know-how, customization and embryologist-oriented designs. Chinese producers including VitaVitro, DEWIN, WEGO Shingene Medical, Lingen Precision Medical Products and Minvitro are strengthening domestic supply and widening the competitive field. Competition therefore centers on dimensional consistency, tip design, biological safety testing, clinical familiarity, specification breadth, distributor reach and reliable supply rather than on price alone.
REPORT SCOPE
This report delivers a comprehensive overview of the global ICSI Injection Micropipettes market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding ICSI Injection Micropipettes. The ICSI Injection Micropipettes market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global ICSI Injection Micropipettes market comprehensively. Regional market sizes by Type, by Application, by Inner Diameter, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist ICSI Injection Micropipettes manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Inner Diameter, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for ICSI Injection Micropipettes manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines ICSI Injection Micropipettes sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 ICSI Injection Micropipettes Market Overview
1.1 Product Definition
1.2 ICSI Injection Micropipettes by Type
1.2.1 Global ICSI Injection Micropipettes Market Value by Type: 2025 vs 2032
1.2.2 Spiked
1.2.3 Non-Spiked
1.3 ICSI Injection Micropipettes by Inner Diameter
1.3.1 Global ICSI Injection Micropipettes Market Value by Inner Diameter: 2025 vs 2032
1.3.2 <5.0 μm
1.3.3 5.0–<6.0 μm
1.3.4 ≥6.0 μm
1.4 ICSI Injection Micropipettes by Taper Design
1.4.1 Global ICSI Injection Micropipettes Market Value by Taper Design: 2025 vs 2032
1.4.2 Long Parallel-Wall
1.4.3 Short Parallel-Wall
1.4.4 Rigid-Taper
1.5 ICSI Injection Micropipettes by Application
1.5.1 Global ICSI Injection Micropipettes Market Value by Application: 2025 vs 2032
1.5.2 Fertility Clinics and IVF Centers
1.5.3 Hospital-Based Reproductive Medicine Centers
1.5.4 Academic and Research Laboratories
1.5.5 Others
1.6 Global ICSI Injection Micropipettes Market Size Estimates and Forecasts
1.6.1 Global ICSI Injection Micropipettes Revenue 2021–2032
1.6.2 Global ICSI Injection Micropipettes Sales 2021–2032
1.6.3 Global ICSI Injection Micropipettes Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 ICSI Injection Micropipettes Market Competition by Manufacturers
2.1 Global ICSI Injection Micropipettes Sales Market Share by Manufacturers (2021–2026)
2.2 Global ICSI Injection Micropipettes Revenue Market Share by Manufacturers (2021–2026)
2.3 Global ICSI Injection Micropipettes Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of ICSI Injection Micropipettes, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of ICSI Injection Micropipettes, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of ICSI Injection Micropipettes, Product Types and Applications
2.7 Global Key Manufacturers of ICSI Injection Micropipettes, Date of Entry into the Industry
2.8 Global ICSI Injection Micropipettes Market Competitive Situation and Trends
2.8.1 Global ICSI Injection Micropipettes Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global ICSI Injection Micropipettes Players Market Share by Revenue
2.8.3 Global ICSI Injection Micropipettes Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global ICSI Injection Micropipettes Market Scenario by Region
3.1 Global ICSI Injection Micropipettes Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global ICSI Injection Micropipettes Sales by Region: 2021–2032
3.2.1 Global ICSI Injection Micropipettes Sales by Region: 2021–2026
3.2.2 Global ICSI Injection Micropipettes Sales by Region: 2027–2032
3.3 Global ICSI Injection Micropipettes Revenue by Region: 2021–2032
3.3.1 Global ICSI Injection Micropipettes Revenue by Region: 2021–2026
3.3.2 Global ICSI Injection Micropipettes Revenue by Region: 2027–2032
3.4 North America ICSI Injection Micropipettes Market Facts & Figures by Country
3.4.1 North America ICSI Injection Micropipettes Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America ICSI Injection Micropipettes Sales by Country (2021–2032)
3.4.3 North America ICSI Injection Micropipettes Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe ICSI Injection Micropipettes Market Facts & Figures by Country
3.5.1 Europe ICSI Injection Micropipettes Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe ICSI Injection Micropipettes Sales by Country (2021–2032)
3.5.3 Europe ICSI Injection Micropipettes Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ICSI Injection Micropipettes Market Facts & Figures by Region
3.6.1 Asia Pacific ICSI Injection Micropipettes Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific ICSI Injection Micropipettes Sales by Region (2021–2032)
3.6.3 Asia Pacific ICSI Injection Micropipettes Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America ICSI Injection Micropipettes Market Facts & Figures by Country
3.7.1 Latin America ICSI Injection Micropipettes Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America ICSI Injection Micropipettes Sales by Country (2021–2032)
3.7.3 Latin America ICSI Injection Micropipettes Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa ICSI Injection Micropipettes Market Facts & Figures by Country
3.8.1 Middle East and Africa ICSI Injection Micropipettes Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa ICSI Injection Micropipettes Sales by Country (2021–2032)
3.8.3 Middle East and Africa ICSI Injection Micropipettes Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ICSI Injection Micropipettes Sales by Type (2021–2032)
4.1.1 Global ICSI Injection Micropipettes Sales by Type (2021–2026)
4.1.2 Global ICSI Injection Micropipettes Sales by Type (2027–2032)
4.1.3 Global ICSI Injection Micropipettes Sales Market Share by Type (2021–2032)
4.2 Global ICSI Injection Micropipettes Revenue by Type (2021–2032)
4.2.1 Global ICSI Injection Micropipettes Revenue by Type (2021–2026)
4.2.2 Global ICSI Injection Micropipettes Revenue by Type (2027–2032)
4.2.3 Global ICSI Injection Micropipettes Revenue Market Share by Type (2021–2032)
4.3 Global ICSI Injection Micropipettes Price by Type (2021–2032)
5 Segment by Application
5.1 Global ICSI Injection Micropipettes Sales by Application (2021–2032)
5.1.1 Global ICSI Injection Micropipettes Sales by Application (2021–2026)
5.1.2 Global ICSI Injection Micropipettes Sales by Application (2027–2032)
5.1.3 Global ICSI Injection Micropipettes Sales Market Share by Application (2021–2032)
5.2 Global ICSI Injection Micropipettes Revenue by Application (2021–2032)
5.2.1 Global ICSI Injection Micropipettes Revenue by Application (2021–2026)
5.2.2 Global ICSI Injection Micropipettes Revenue by Application (2027–2032)
5.2.3 Global ICSI Injection Micropipettes Revenue Market Share by Application (2021–2032)
5.3 Global ICSI Injection Micropipettes Price by Application (2021–2032)
6 Key Companies Profiled
6.1 CooperSurgical
6.1.1 CooperSurgical Company Information
6.1.2 CooperSurgical Description and Business Overview
6.1.3 CooperSurgical ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 CooperSurgical ICSI Injection Micropipettes Product Portfolio
6.1.5 CooperSurgical Recent Developments/Updates
6.2 Nexpring Health
6.2.1 Nexpring Health Company Information
6.2.2 Nexpring Health Description and Business Overview
6.2.3 Nexpring Health ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nexpring Health ICSI Injection Micropipettes Product Portfolio
6.2.5 Nexpring Health Recent Developments/Updates
6.3 Vitrolife
6.3.1 Vitrolife Company Information
6.3.2 Vitrolife Description and Business Overview
6.3.3 Vitrolife ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Vitrolife ICSI Injection Micropipettes Product Portfolio
6.3.5 Vitrolife Recent Developments/Updates
6.4 Kitazato
6.4.1 Kitazato Company Information
6.4.2 Kitazato Description and Business Overview
6.4.3 Kitazato ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Kitazato ICSI Injection Micropipettes Product Portfolio
6.4.5 Kitazato Recent Developments/Updates
6.5 Sunlight Medical
6.5.1 Sunlight Medical Company Information
6.5.2 Sunlight Medical Description and Business Overview
6.5.3 Sunlight Medical ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sunlight Medical ICSI Injection Micropipettes Product Portfolio
6.5.5 Sunlight Medical Recent Developments/Updates
6.6 VITROMED
6.6.1 VITROMED Company Information
6.6.2 VITROMED Description and Business Overview
6.6.3 VITROMED ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 VITROMED ICSI Injection Micropipettes Product Portfolio
6.6.5 VITROMED Recent Developments/Updates
6.7 ASTEC
6.7.1 ASTEC Company Information
6.7.2 ASTEC Description and Business Overview
6.7.3 ASTEC ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ASTEC ICSI Injection Micropipettes Product Portfolio
6.7.5 ASTEC Recent Developments/Updates
6.8 Labotect
6.8.1 Labotect Company Information
6.8.2 Labotect Description and Business Overview
6.8.3 Labotect ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Labotect ICSI Injection Micropipettes Product Portfolio
6.8.5 Labotect Recent Developments/Updates
6.9 Thomas Medical
6.9.1 Thomas Medical Company Information
6.9.2 Thomas Medical Description and Business Overview
6.9.3 Thomas Medical ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Thomas Medical ICSI Injection Micropipettes Product Portfolio
6.9.5 Thomas Medical Recent Developments/Updates
6.10 Microtech IVF
6.10.1 Microtech IVF Company Information
6.10.2 Microtech IVF Description and Business Overview
6.10.3 Microtech IVF ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Microtech IVF ICSI Injection Micropipettes Product Portfolio
6.10.5 Microtech IVF Recent Developments/Updates
6.11 Synga
6.11.1 Synga Company Information
6.11.2 Synga Description and Business Overview
6.11.3 Synga ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Synga ICSI Injection Micropipettes Product Portfolio
6.11.5 Synga Recent Developments/Updates
6.12 ARSCI
6.12.1 ARSCI Company Information
6.12.2 ARSCI Description and Business Overview
6.12.3 ARSCI ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 ARSCI ICSI Injection Micropipettes Product Portfolio
6.12.5 ARSCI Recent Developments/Updates
6.13 Optimas
6.13.1 Optimas Company Information
6.13.2 Optimas Description and Business Overview
6.13.3 Optimas ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Optimas ICSI Injection Micropipettes Product Portfolio
6.13.5 Optimas Recent Developments/Updates
6.14 ICSION Medical
6.14.1 ICSION Medical Company Information
6.14.2 ICSION Medical Description and Business Overview
6.14.3 ICSION Medical ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 ICSION Medical ICSI Injection Micropipettes Product Portfolio
6.14.5 ICSION Medical Recent Developments/Updates
6.15 Monash Biotech
6.15.1 Monash Biotech Company Information
6.15.2 Monash Biotech Description and Business Overview
6.15.3 Monash Biotech ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Monash Biotech ICSI Injection Micropipettes Product Portfolio
6.15.5 Monash Biotech Recent Developments/Updates
6.16 Reproline medical
6.16.1 Reproline medical Company Information
6.16.2 Reproline medical Description and Business Overview
6.16.3 Reproline medical ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Reproline medical ICSI Injection Micropipettes Product Portfolio
6.16.5 Reproline medical Recent Developments/Updates
6.17 TechBruein
6.17.1 TechBruein Company Information
6.17.2 TechBruein Description and Business Overview
6.17.3 TechBruein ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 TechBruein ICSI Injection Micropipettes Product Portfolio
6.17.5 TechBruein Recent Developments/Updates
6.18 SASOmed
6.18.1 SASOmed Company Information
6.18.2 SASOmed Description and Business Overview
6.18.3 SASOmed ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 SASOmed ICSI Injection Micropipettes Product Portfolio
6.18.5 SASOmed Recent Developments/Updates
6.19 VitaVitro
6.19.1 VitaVitro Company Information
6.19.2 VitaVitro Description and Business Overview
6.19.3 VitaVitro ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 VitaVitro ICSI Injection Micropipettes Product Portfolio
6.19.5 VitaVitro Recent Developments/Updates
6.20 DEWIN
6.20.1 DEWIN Company Information
6.20.2 DEWIN Description and Business Overview
6.20.3 DEWIN ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 DEWIN ICSI Injection Micropipettes Product Portfolio
6.20.5 DEWIN Recent Developments/Updates
6.21 WEGO Shingene Medical
6.21.1 WEGO Shingene Medical Company Information
6.21.2 WEGO Shingene Medical Description and Business Overview
6.21.3 WEGO Shingene Medical ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 WEGO Shingene Medical ICSI Injection Micropipettes Product Portfolio
6.21.5 WEGO Shingene Medical Recent Developments/Updates
6.22 Lingen Precision Medical Products
6.22.1 Lingen Precision Medical Products Company Information
6.22.2 Lingen Precision Medical Products Description and Business Overview
6.22.3 Lingen Precision Medical Products ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Lingen Precision Medical Products ICSI Injection Micropipettes Product Portfolio
6.22.5 Lingen Precision Medical Products Recent Developments/Updates
6.23 Diagens Bio
6.23.1 Diagens Bio Company Information
6.23.2 Diagens Bio Description and Business Overview
6.23.3 Diagens Bio ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Diagens Bio ICSI Injection Micropipettes Product Portfolio
6.23.5 Diagens Bio Recent Developments/Updates
6.24 Minvitro
6.24.1 Minvitro Company Information
6.24.2 Minvitro Description and Business Overview
6.24.3 Minvitro ICSI Injection Micropipettes Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Minvitro ICSI Injection Micropipettes Product Portfolio
6.24.5 Minvitro Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ICSI Injection Micropipettes Industry Chain Analysis
7.2 ICSI Injection Micropipettes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ICSI Injection Micropipettes Production Mode & Process Analysis
7.4 ICSI Injection Micropipettes Sales and Marketing
7.4.1 ICSI Injection Micropipettes Sales Channels
7.4.2 ICSI Injection Micropipettes Distributors
7.5 ICSI Injection Micropipettes Customer Analysis
8 ICSI Injection Micropipettes Market Dynamics
8.1 ICSI Injection Micropipettes Industry Trends
8.2 ICSI Injection Micropipettes Market Drivers
8.3 ICSI Injection Micropipettes Market Challenges
8.4 ICSI Injection Micropipettes Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global ICSI Injection Micropipettes Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global ICSI Injection Micropipettes Market Value by Inner Diameter (US$ Million), 2025 vs 2032
Table 3. Global ICSI Injection Micropipettes Market Value by Taper Design (US$ Million), 2025 vs 2032
Table 4. Global ICSI Injection Micropipettes Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global ICSI Injection Micropipettes Market Competitive Situation by Manufacturers in 2025
Table 6. Global ICSI Injection Micropipettes Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global ICSI Injection Micropipettes Sales Market Share by Manufacturers (2021–2026)
Table 8. Global ICSI Injection Micropipettes Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global ICSI Injection Micropipettes Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market ICSI Injection Micropipettes Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of ICSI Injection Micropipettes, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of ICSI Injection Micropipettes, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of ICSI Injection Micropipettes, Product Types and Applications
Table 14. Global Key Manufacturers of ICSI Injection Micropipettes, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global ICSI Injection Micropipettes Companies by Tier (Tier 1, Tier 2, Tier 3), based on ICSI Injection Micropipettes Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global ICSI Injection Micropipettes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global ICSI Injection Micropipettes Sales by Region (K Units), 2021–2026
Table 20. Global ICSI Injection Micropipettes Sales Market Share by Region (2021–2026)
Table 21. Global ICSI Injection Micropipettes Sales by Region (K Units), 2027–2032
Table 22. Global ICSI Injection Micropipettes Sales Market Share by Region (2027–2032)
Table 23. Global ICSI Injection Micropipettes Revenue by Region (US$ Million), 2021–2026
Table 24. Global ICSI Injection Micropipettes Revenue Market Share by Region (2021–2026)
Table 25. Global ICSI Injection Micropipettes Revenue by Region (US$ Million), 2027–2032
Table 26. Global ICSI Injection Micropipettes Revenue Market Share by Region (2027–2032)
Table 27. North America ICSI Injection Micropipettes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America ICSI Injection Micropipettes Sales by Country (K Units), 2021–2026
Table 29. North America ICSI Injection Micropipettes Sales by Country (K Units), 2027–2032
Table 30. North America ICSI Injection Micropipettes Revenue by Country (US$ Million), 2021–2026
Table 31. North America ICSI Injection Micropipettes Revenue by Country (US$ Million), 2027–2032
Table 32. Europe ICSI Injection Micropipettes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe ICSI Injection Micropipettes Sales by Country (K Units), 2021–2026
Table 34. Europe ICSI Injection Micropipettes Sales by Country (K Units), 2027–2032
Table 35. Europe ICSI Injection Micropipettes Revenue by Country (US$ Million), 2021–2026
Table 36. Europe ICSI Injection Micropipettes Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific ICSI Injection Micropipettes Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific ICSI Injection Micropipettes Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific ICSI Injection Micropipettes Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific ICSI Injection Micropipettes Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific ICSI Injection Micropipettes Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America ICSI Injection Micropipettes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America ICSI Injection Micropipettes Sales by Country (K Units), 2021–2026
Table 44. Latin America ICSI Injection Micropipettes Sales by Country (K Units), 2027–2032
Table 45. Latin America ICSI Injection Micropipettes Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America ICSI Injection Micropipettes Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa ICSI Injection Micropipettes Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa ICSI Injection Micropipettes Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa ICSI Injection Micropipettes Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa ICSI Injection Micropipettes Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa ICSI Injection Micropipettes Revenue by Country (US$ Million), 2027–2032
Table 52. Global ICSI Injection Micropipettes Sales (K Units) by Type (2021–2026)
Table 53. Global ICSI Injection Micropipettes Sales (K Units) by Type (2027–2032)
Table 54. Global ICSI Injection Micropipettes Sales Market Share by Type (2021–2026)
Table 55. Global ICSI Injection Micropipettes Sales Market Share by Type (2027–2032)
Table 56. Global ICSI Injection Micropipettes Revenue (US$ Million) by Type (2021–2026)
Table 57. Global ICSI Injection Micropipettes Revenue (US$ Million) by Type (2027–2032)
Table 58. Global ICSI Injection Micropipettes Revenue Market Share by Type (2021–2026)
Table 59. Global ICSI Injection Micropipettes Revenue Market Share by Type (2027–2032)
Table 60. Global ICSI Injection Micropipettes Price (US$/Unit) by Type (2021–2026)
Table 61. Global ICSI Injection Micropipettes Price (US$/Unit) by Type (2027–2032)
Table 62. Global ICSI Injection Micropipettes Sales (K Units) by Application (2021–2026)
Table 63. Global ICSI Injection Micropipettes Sales (K Units) by Application (2027–2032)
Table 64. Global ICSI Injection Micropipettes Sales Market Share by Application (2021–2026)
Table 65. Global ICSI Injection Micropipettes Sales Market Share by Application (2027–2032)
Table 66. Global ICSI Injection Micropipettes Revenue (US$ Million) by Application (2021–2026)
Table 67. Global ICSI Injection Micropipettes Revenue (US$ Million) by Application (2027–2032)
Table 68. Global ICSI Injection Micropipettes Revenue Market Share by Application (2021–2026)
Table 69. Global ICSI Injection Micropipettes Revenue Market Share by Application (2027–2032)
Table 70. Global ICSI Injection Micropipettes Price (US$/Unit) by Application (2021–2026)
Table 71. Global ICSI Injection Micropipettes Price (US$/Unit) by Application (2027–2032)
Table 72. CooperSurgical Company Information
Table 73. CooperSurgical Description and Business Overview
Table 74. CooperSurgical ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. CooperSurgical ICSI Injection Micropipettes Product
Table 76. CooperSurgical Recent Developments/Updates
Table 77. Nexpring Health Company Information
Table 78. Nexpring Health Description and Business Overview
Table 79. Nexpring Health ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Nexpring Health ICSI Injection Micropipettes Product
Table 81. Nexpring Health Recent Developments/Updates
Table 82. Vitrolife Company Information
Table 83. Vitrolife Description and Business Overview
Table 84. Vitrolife ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Vitrolife ICSI Injection Micropipettes Product
Table 86. Vitrolife Recent Developments/Updates
Table 87. Kitazato Company Information
Table 88. Kitazato Description and Business Overview
Table 89. Kitazato ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Kitazato ICSI Injection Micropipettes Product
Table 91. Kitazato Recent Developments/Updates
Table 92. Sunlight Medical Company Information
Table 93. Sunlight Medical Description and Business Overview
Table 94. Sunlight Medical ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Sunlight Medical ICSI Injection Micropipettes Product
Table 96. Sunlight Medical Recent Developments/Updates
Table 97. VITROMED Company Information
Table 98. VITROMED Description and Business Overview
Table 99. VITROMED ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. VITROMED ICSI Injection Micropipettes Product
Table 101. VITROMED Recent Developments/Updates
Table 102. ASTEC Company Information
Table 103. ASTEC Description and Business Overview
Table 104. ASTEC ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. ASTEC ICSI Injection Micropipettes Product
Table 106. ASTEC Recent Developments/Updates
Table 107. Labotect Company Information
Table 108. Labotect Description and Business Overview
Table 109. Labotect ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Labotect ICSI Injection Micropipettes Product
Table 111. Labotect Recent Developments/Updates
Table 112. Thomas Medical Company Information
Table 113. Thomas Medical Description and Business Overview
Table 114. Thomas Medical ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Thomas Medical ICSI Injection Micropipettes Product
Table 116. Thomas Medical Recent Developments/Updates
Table 117. Microtech IVF Company Information
Table 118. Microtech IVF Description and Business Overview
Table 119. Microtech IVF ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Microtech IVF ICSI Injection Micropipettes Product
Table 121. Microtech IVF Recent Developments/Updates
Table 122. Synga Company Information
Table 123. Synga Description and Business Overview
Table 124. Synga ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Synga ICSI Injection Micropipettes Product
Table 126. Synga Recent Developments/Updates
Table 127. ARSCI Company Information
Table 128. ARSCI Description and Business Overview
Table 129. ARSCI ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. ARSCI ICSI Injection Micropipettes Product
Table 131. ARSCI Recent Developments/Updates
Table 132. Optimas Company Information
Table 133. Optimas Description and Business Overview
Table 134. Optimas ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. Optimas ICSI Injection Micropipettes Product
Table 136. Optimas Recent Developments/Updates
Table 137. ICSION Medical Company Information
Table 138. ICSION Medical Description and Business Overview
Table 139. ICSION Medical ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. ICSION Medical ICSI Injection Micropipettes Product
Table 141. ICSION Medical Recent Developments/Updates
Table 142. Monash Biotech Company Information
Table 143. Monash Biotech Description and Business Overview
Table 144. Monash Biotech ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Monash Biotech ICSI Injection Micropipettes Product
Table 146. Monash Biotech Recent Developments/Updates
Table 147. Reproline medical Company Information
Table 148. Reproline medical Description and Business Overview
Table 149. Reproline medical ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Reproline medical ICSI Injection Micropipettes Product
Table 151. Reproline medical Recent Developments/Updates
Table 152. TechBruein Company Information
Table 153. TechBruein Description and Business Overview
Table 154. TechBruein ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. TechBruein ICSI Injection Micropipettes Product
Table 156. TechBruein Recent Developments/Updates
Table 157. SASOmed Company Information
Table 158. SASOmed Description and Business Overview
Table 159. SASOmed ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 160. SASOmed ICSI Injection Micropipettes Product
Table 161. SASOmed Recent Developments/Updates
Table 162. VitaVitro Company Information
Table 163. VitaVitro Description and Business Overview
Table 164. VitaVitro ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 165. VitaVitro ICSI Injection Micropipettes Product
Table 166. VitaVitro Recent Developments/Updates
Table 167. DEWIN Company Information
Table 168. DEWIN Description and Business Overview
Table 169. DEWIN ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 170. DEWIN ICSI Injection Micropipettes Product
Table 171. DEWIN Recent Developments/Updates
Table 172. WEGO Shingene Medical Company Information
Table 173. WEGO Shingene Medical Description and Business Overview
Table 174. WEGO Shingene Medical ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 175. WEGO Shingene Medical ICSI Injection Micropipettes Product
Table 176. WEGO Shingene Medical Recent Developments/Updates
Table 177. Lingen Precision Medical Products Company Information
Table 178. Lingen Precision Medical Products Description and Business Overview
Table 179. Lingen Precision Medical Products ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 180. Lingen Precision Medical Products ICSI Injection Micropipettes Product
Table 181. Lingen Precision Medical Products Recent Developments/Updates
Table 182. Diagens Bio Company Information
Table 183. Diagens Bio Description and Business Overview
Table 184. Diagens Bio ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 185. Diagens Bio ICSI Injection Micropipettes Product
Table 186. Diagens Bio Recent Developments/Updates
Table 187. Minvitro Company Information
Table 188. Minvitro Description and Business Overview
Table 189. Minvitro ICSI Injection Micropipettes Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 190. Minvitro ICSI Injection Micropipettes Product
Table 191. Minvitro Recent Developments/Updates
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. ICSI Injection Micropipettes Distributors List
Table 195. ICSI Injection Micropipettes Customers List
Table 196. ICSI Injection Micropipettes Market Trends
Table 197. ICSI Injection Micropipettes Market Drivers
Table 198. ICSI Injection Micropipettes Market Challenges
Table 199. ICSI Injection Micropipettes Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
Table 203. Authors List of This Report
List of Figures
Figure 1. Product Picture of ICSI Injection Micropipettes
Figure 2. Global ICSI Injection Micropipettes Market Value by Type (US$ Million), 2021–2032
Figure 3. Global ICSI Injection Micropipettes Market Share by Type: 2025 & 2032
Figure 4. Spiked Product Picture
Figure 5. Non-Spiked Product Picture
Figure 6. Global ICSI Injection Micropipettes Market Value by Inner Diameter (US$ Million), 2021–2032
Figure 7. Global ICSI Injection Micropipettes Market Share by Inner Diameter: 2025 vs 2032
Figure 8. <5.0 μm Product Picture
Figure 9. 5.0–<6.0 μm Product Picture
Figure 10. ≥6.0 μm Product Picture
Figure 11. Global ICSI Injection Micropipettes Market Value by Taper Design (US$ Million), 2021–2032
Figure 12. Global ICSI Injection Micropipettes Market Share by Taper Design: 2025 vs 2032
Figure 13. Long Parallel-Wall Product Picture
Figure 14. Short Parallel-Wall Product Picture
Figure 15. Rigid-Taper Product Picture
Figure 16. Global ICSI Injection Micropipettes Market Value by Application (US$ Million), 2021–2032
Figure 17. Global ICSI Injection Micropipettes Market Share by Application: 2025 & 2032
Figure 18. Fertility Clinics and IVF Centers
Figure 19. Hospital-Based Reproductive Medicine Centers
Figure 20. Academic and Research Laboratories
Figure 21. Others
Figure 22. Global ICSI Injection Micropipettes Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global ICSI Injection Micropipettes Market Size (US$ Million), 2021–2032
Figure 24. Global ICSI Injection Micropipettes Sales (K Units), 2021–2032
Figure 25. Global ICSI Injection Micropipettes Average Price (US$/Unit), 2021–2032
Figure 26. ICSI Injection Micropipettes Report Years Considered
Figure 27. ICSI Injection Micropipettes Sales Share by Manufacturers in 2025
Figure 28. Global ICSI Injection Micropipettes Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global ICSI Injection Micropipettes Players: Market Share by Revenue in ICSI Injection Micropipettes in 2025
Figure 30. ICSI Injection Micropipettes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global ICSI Injection Micropipettes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America ICSI Injection Micropipettes Sales Market Share by Country (2021–2032)
Figure 33. North America ICSI Injection Micropipettes Revenue Market Share by Country (2021–2032)
Figure 34. United States ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe ICSI Injection Micropipettes Sales Market Share by Country (2021–2032)
Figure 37. Europe ICSI Injection Micropipettes Revenue Market Share by Country (2021–2032)
Figure 38. Germany ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific ICSI Injection Micropipettes Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific ICSI Injection Micropipettes Revenue Market Share by Region (2021–2032)
Figure 45. China ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. China Taiwan ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Southeast Asia ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Latin America ICSI Injection Micropipettes Sales Market Share by Country (2021–2032)
Figure 53. Latin America ICSI Injection Micropipettes Revenue Market Share by Country (2021–2032)
Figure 54. Mexico ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Brazil ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Argentina ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Colombia ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa ICSI Injection Micropipettes Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa ICSI Injection Micropipettes Revenue Market Share by Country (2021–2032)
Figure 60. Turkey ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE ICSI Injection Micropipettes Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of ICSI Injection Micropipettes by Type (2021–2032)
Figure 64. Global Revenue Market Share of ICSI Injection Micropipettes by Type (2021–2032)
Figure 65. Global ICSI Injection Micropipettes Price (US$/Unit) by Type (2021–2032)
Figure 66. Global Sales Market Share of ICSI Injection Micropipettes by Application (2021–2032)
Figure 67. Global Revenue Market Share of ICSI Injection Micropipettes by Application (2021–2032)
Figure 68. Global ICSI Injection Micropipettes Price (US$/Unit) by Application (2021–2032)
Figure 69. ICSI Injection Micropipettes Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of ICSI Injection Micropipettes in 2026?
The global market size of ICSI Injection Micropipettes in 2026 was 40.79 Million USD.
What was the global market size of ICSI Injection Micropipettes in 2032?
Which companies rank high in the global ICSI Injection Micropipettes market?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global ICSI Injection Micropipettes market size from 2026 to 2032?
Related Reports
Global ICSI Injection Micropipettes Market Outlook, In‑Depth Analysis & Forecast to 2032
The global ICSI Injection Micropipettes market is projected to grow from US$ 38.72 million in 2025 to US$ 55.96 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-14
Pages: 182
USD 4900.00
(Single User License)
Global ICSI Injection Micropipettes Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global ICSI Injection Micropipettes market size was US$ 38.72 million in 2025 and is forecast to reach a readjusted size of US$ 55.96 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-08-14
Pages: 160
USD 4250.00
(Single User License)
ICSI Injection Micropipettes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for ICSI Injection Micropipettes was estimated to be worth US$ 38.72 million in 2025 and is projected to reach US$ 55.96 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-08-14
Pages: 160
USD 3950.00
(Single User License)
Global ICSI Injection Micropipettes Market Outlook, In‑Depth Analysis & Forecast to 2031
The global ICSI Injection Micropipettes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 153
USD 4900.00
(Single User License)
Global ICSI Injection Micropipettes Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global ICSI Injection Micropipettes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 95
USD 4250.00
(Single User License)
ICSI Injection Micropipettes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for ICSI Injection Micropipettes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
Global ICSI Injection Micropipettes Market Research Report 2025
The global market for ICSI Injection Micropipettes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 90
USD 2900.00
(Single User License)
Global and United States ICSI Injection Micropipettes Market Report & Forecast 2024-2030
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published Date: 2024-05-23
Pages: 128
USD 4350.00
(Single User License)
ICSI Injection Micropipettes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published Date: 2024-05-23
Pages: 124
USD 3950.00
(Single User License)
Global ICSI Injection Micropipettes Market Research Report 2024
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published Date: 2024-05-23
Pages: 89
USD 2900.00
(Single User License)
Global ICSI Injection Micropipettes Market Outlook, In‑Depth Analysis & Forecast to 2032
The global ICSI Injection Micropipettes market is projected to grow from US$ 38.72 million in 2025 to US$ 55.96 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-14
Pages: 182
USD 4900.00 (Single User License)Global ICSI Injection Micropipettes Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global ICSI Injection Micropipettes market size was US$ 38.72 million in 2025 and is forecast to reach a readjusted size of US$ 55.96 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-08-14
Pages: 160
USD 4250.00 (Single User License)ICSI Injection Micropipettes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for ICSI Injection Micropipettes was estimated to be worth US$ 38.72 million in 2025 and is projected to reach US$ 55.96 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-08-14
Pages: 160
USD 3950.00 (Single User License)Global ICSI Injection Micropipettes Market Outlook, In‑Depth Analysis & Forecast to 2031
The global ICSI Injection Micropipettes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 153
USD 4900.00 (Single User License)Global ICSI Injection Micropipettes Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global ICSI Injection Micropipettes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 95
USD 4250.00 (Single User License)ICSI Injection Micropipettes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for ICSI Injection Micropipettes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
USD 3950.00 (Single User License)Global ICSI Injection Micropipettes Market Research Report 2025
The global market for ICSI Injection Micropipettes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 90
USD 2900.00 (Single User License)Global and United States ICSI Injection Micropipettes Market Report & Forecast 2024-2030
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published: 2024-05-23
Pages: 128
USD 4350.00 (Single User License)ICSI Injection Micropipettes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published: 2024-05-23
Pages: 124
USD 3950.00 (Single User License)Global ICSI Injection Micropipettes Market Research Report 2024
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published: 2024-05-23
Pages: 89
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
COMPETITIVE LANDSCAPE ANALYSIS
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now